IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q4 2018 Holdings

Filed 2019-02-06 | 7 holdings | $86.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$22.0K1,615,32125.4%
Surface Oncology IncCOM86877M209$19.7K4,645,45322.7%
Synlogic IncCOM87166L100$18.6K2,651,96321.4%
Unum Therapeutics IncCOM903214104$14.8K3,361,53517.0%
Spero Therapeutics Inc(SPRO)COM84833T103$8.5K1,376,9689.7%
Carbon Black IncCOM14081R103$2.4K181,2732.8%
Snap Inc(SNAP)CL A83304A106$827150,1601.0%